- CA$11.66bn
- CA$14.92bn
- CA$4.71bn
- 81
- 47
- 89
- 84
Annual income statement for Cae, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,982 | 3,371 | 4,011 | 4,283 | 4,708 |
| Cost of Revenue | |||||
| Gross Profit | 765 | 956 | 1,084 | 1,155 | 1,300 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,934 | 3,087 | 3,545 | 4,468 | 3,979 |
| Operating Profit | 48.4 | 284 | 466 | -185 | 729 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -87.2 | 154 | 292 | -390 | 514 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -47.5 | 150 | 230 | -318 | 415 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -47.2 | 142 | 223 | -304 | 405 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -47.2 | 142 | 223 | -304 | 405 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | 0.862 | 0.84 | 0.466 | 1.38 |